|
Jun 11
|
Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 2.7% over the last three years
|
|
Jun 11
|
The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Verizon, Taylor Devices and Frequency Electronics
|
|
Jun 11
|
Time to Pounce: 2 High-Yielding Dow Stocks That Are Begging to Be Bought Right Now
|
|
Jun 10
|
Earnings Season Update and Analyst Reports for Broadcom, JNJ & Verizon
|
|
Jun 10
|
J&J wins expanded FDA clearance for knee surgery robot
|
|
Jun 10
|
Pulsed field ablation to ‘cannibalize’ radiofrequency, cryo: Needham
|
|
Jun 7
|
3 Dow Stocks That Are No-Brainer Buys in June
|
|
Jun 6
|
Is Johnson & Johnson (NYSE:JNJ) the Best Mega-Cap Dividend Aristocrat Stock?
|
|
Jun 6
|
Is Johnson & Johnson A Good Quality Stock to Buy Now?
|
|
Jun 6
|
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
|
|
Jun 5
|
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jun 5
|
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
|
|
Jun 5
|
J&J seeks expanded approvals for paediatric HIV-1 therapy
|
|
May 21
|
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
|
|
May 21
|
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
|
|
May 21
|
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
|
|
May 20
|
Pulsed field ablation poised for fast adoption, analysts say
|
|
May 20
|
Johnson & Johnson's Dividend Analysis
|
|
May 20
|
J&J posts latest Varipulse data while awaiting FDA review
|
|
May 17
|
Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
|